Biovail CEO Tries To Muscle Back Into Bankruptcy Case
Struggling to regain control over Hemosol Corp.'s restructuring, Biovail Corp. chairman Eugene Melnyk is purportedly preparing to challenge a private equity fund that unexpectedly wrested authority from him in the insolvent...To view the full article, register now.
Already a subscriber? Click here to view full article